AIMS/HYPOTHESIS: In epidemiological and genetic studies surrogate indices are needed to investigate insulin resistance in different insulin-sensitive tissues. Our objective was to develop a surrogate index for hepatic insulin resistance. METHODS: A sample of 368 non-diabetic participants (age 43.0 ± 8.2 years, BMI 26.0 ± 4.0 kg/m(2); mean ± SD) whose endogenous glucose production (EGP) was measured with [6-6(2)H(2)]glucose in the fasting state and during the euglycaemic-hyperinsulinaemic clamp were included in the study. EGP multiplied by fasting plasma insulin (FPI) concentration was the reference measurement for liver insulin resistance (liver IR). Liver IR index was calculated with linear regression analysis including age, obesity indices, lipids, lipoproteins and several variables regulating glucose metabolism. RESULTS: The following variables were significantly associated with liver IR in multiple forward stepwise regression analysis: insulin AUC in an OGTT, fat mass, HDL-cholesterol and BMI. Liver IR index correlated significantly with EGP×FPI (r = 0.65, p < 0.001). In participants with abnormal glucose tolerance, the correlation of liver IR with EGP×FPI was slightly stronger (r = 0.69, p < 0.001) than in those with normal glucose tolerance (r = 0.62, p < 0.001). CONCLUSIONS/ INTERPRETATION: We generated a novel surrogate index for liver insulin resistance correlating strongly with EGP × FPI.
AIMS/HYPOTHESIS: In epidemiological and genetic studies surrogate indices are needed to investigate insulin resistance in different insulin-sensitive tissues. Our objective was to develop a surrogate index for hepatic insulin resistance. METHODS: A sample of 368 non-diabeticparticipants (age 43.0 ± 8.2 years, BMI 26.0 ± 4.0 kg/m(2); mean ± SD) whose endogenous glucose production (EGP) was measured with [6-6(2)H(2)]glucose in the fasting state and during the euglycaemic-hyperinsulinaemic clamp were included in the study. EGP multiplied by fasting plasma insulin (FPI) concentration was the reference measurement for liver insulin resistance (liver IR). Liver IR index was calculated with linear regression analysis including age, obesity indices, lipids, lipoproteins and several variables regulating glucose metabolism. RESULTS: The following variables were significantly associated with liver IR in multiple forward stepwise regression analysis: insulin AUC in an OGTT, fat mass, HDL-cholesterol and BMI. Liver IR index correlated significantly with EGP×FPI (r = 0.65, p < 0.001). In participants with abnormal glucose tolerance, the correlation of liver IR with EGP×FPI was slightly stronger (r = 0.69, p < 0.001) than in those with normal glucose tolerance (r = 0.62, p < 0.001). CONCLUSIONS/ INTERPRETATION: We generated a novel surrogate index for liver insulin resistance correlating strongly with EGP × FPI.
Authors: S A Hills; B Balkau; S W Coppack; J M Dekker; A Mari; A Natali; M Walker; E Ferrannini Journal: Diabetologia Date: 2004-02-14 Impact factor: 10.122
Authors: Sudha B Biddinger; Antonio Hernandez-Ono; Christian Rask-Madsen; Joel T Haas; José O Alemán; Ryo Suzuki; Erez F Scapa; Chhavi Agarwal; Martin C Carey; Gregory Stephanopoulos; David E Cohen; George L King; Henry N Ginsberg; C Ronald Kahn Journal: Cell Metab Date: 2008-02 Impact factor: 27.287
Authors: J Otten; C Mellberg; M Ryberg; S Sandberg; J Kullberg; B Lindahl; C Larsson; J Hauksson; T Olsson Journal: Int J Obes (Lond) Date: 2016-01-20 Impact factor: 5.095
Authors: J Vangipurapu; A Stančáková; J Pihlajamäki; T M Kuulasmaa; T Kuulasmaa; J Paananen; J Kuusisto; E Ferrannini; M Laakso Journal: Diabetologia Date: 2010-12-12 Impact factor: 10.122
Authors: Domenico Tricò; Alessandro Mengozzi; Lorenzo Nesti; Mensud Hatunic; Rafael Gabriel Sanchez; Thomas Konrad; Katarina Lalić; Nebojša M Lalić; Andrea Mari; Andrea Natali Journal: Diabetologia Date: 2019-11-01 Impact factor: 10.122
Authors: Angela Sciacqua; Maria Adelaide Marini; Marta Letizia Hribal; Francesco Perticone; Giorgio Sesti Journal: PLoS One Date: 2013-01-09 Impact factor: 3.240